Ambulatory Infusion Pump Market Shows Rapid Growth

The use of ambulatory infusion pumps, which allow the patient to remain mobile while undergoing treatment, is increasing rapidly worldwide. These are the latest findings of InMedica (Wellingborough, UK), a market research firm.

With increasing pressure on governments to improve the quality of care, while reducing the burden of healthcare funding, hospitals are seeking more cost-effective solutions. Increasingly, these include reducing hospital visits through outpatient and home-care solutions, which are seeing the strongest growth in the Americas, Europe, Middle East, and African (EMEA) regions. This has led to a growing trend for infusion products that can be used safely at home, or in a long-term managed care environment. Moreover, as age-related diseases increase, demand for long-term care is on the rise.

These factors are fuelling the market for home-based ambulatory infusion pumps, which are used to administer a variety of therapies, including analgesics, narcotics, chemotherapy, and antibiotic or anitiviral infusions. InMedica projects that demand for home-based ambulatory products in the Americas and EMEA regions will increase from an estimated 5.2 million units in 2010 to 8.1 million units in 2015, a compound annual growth rate of 9.3%. Worldwide, the 19.1 million units shipped in 2010 are estimated to increase to 35.3 million units in 2015.

“Hospitals are seeking to optimize the cost-effectiveness of treatments, to reduce healthcare spending; in addition, in many developed countries, such as North America and Western Europe, treatments are being moved into an out-patient environment, to further lower costs,” said Stacey Ronaghan, a market analyst at InMedica. “The observed trend towards out-of-hospital treatment and use of ambulatory infusion pumps, particularly in pain management, will serve to reduce the cost of care from a hospital perspective.”

Related Links:
InMedica